INVESTOR PARTNERS
Backed by Leading Institutional Investors
Following our $8.5 million Series A financing round, Omeza is proud to partner with visionary investors who share our commitment to transforming the multi-billion-dollar advanced wound care market. Together, we are accelerating clinical trials, expanding nationwide commercial capabilities, and scaling our FDA-cleared regenerative therapies to address the global burden of hard-to-heal wounds.
Astanor Ventures
Astanor is a global impact investment firm with $1B in assets under management, backing seed-through growth-stage companies at the intersection of healthspan, nature, and physical AI. Founded in 2017, Astanor counts circa 50 investments to date in Europe, North America and beyond. The firm partners with visionary entrepreneurs and management teams building scalable solutions across agriculture, food production, and healthcare, applying robotics, AI, and nature-based science to advance human and planetary health. More information is available at www.astanor.com
Catalyst Ventures
Catalyst Investments is an Israel-based private equity multi-fund firm with over 25 years of experience investing in high-growth technology and life science companies. Founded by Edouard Cukierman, Catalyst focuses on disruptive, internationally scalable companies with an Israel nexus across sectors including enterprise SaaS, cybersecurity, life sciences, climate tech, and smart mobility. The firm leverages a global network spanning the United States, Europe, Asia, and emerging markets to support portfolio companies with capital, strategic guidance, and cross-border expansion. Cukierman & Co. Investment House, the affiliated investment bank, has been engaged in over $10.8 billion of corporate finance transactions since its establishment in 1993. For more information, visit, www.catalyst-fund.com
BluKap Ventures
BluKap Ventures is a global venture capital firm focused exclusively on ocean biotechnology. The firm backs companies developing next-generation therapeutics and technologies derived from ocean biodiversity, with a clear mission to unlock the medical value of sustainably sourced marine compounds. At the crossroads of human health and the blue economy, BluKap advances innovations that convert marine science into scalable, high-impact healthcare solutions. Founded by Henry Gazay and Jean-François Trecco, BluKap combines deep entrepreneurial and investment experience with a strong transatlantic network across healthcare, biotechnology, and marine science ecosystems. The firm provides portfolio companies with capital, strategic guidance, and access to a global network of investors, industry partners, and scientific experts. For more information, visit, www.blukap.vc
Connect with Our Experts
Direct your inquiry to the appropriate Omeza division, clinical, scientific, or corporate, and let's advance the future of wound care together.
Contact Us